Health Mobile Cognitive Stimulation in Alcoholics
This trial is active, not recruiting.
|Conditions||alcohol-induced disorders, nervous system, alcohol dependence|
|Treatment||mobile health cognitive stimulation|
|Collaborator||Universidade Lusófona de Humanidades e Tecnologias|
|Start date||October 2012|
|End date||March 2013|
|Trial size||54 participants|
|Trial identifier||NCT01942954, labpsicom-001|
The consequences of alcohol dependence are severe and may range from physical diseases to neuropsychological deficits in several cognitive domains. Alcohol abuse has also been related to brain dysfunction specifically in the prefrontal cortex. To assess these deficits and the application of a novel approach of cognitive stimulation to alcoholics, we have carried out a neuropsychological intervention program with mobile health technology. Patients diagnosed with alcohol dependence syndrome were submitted to cognitive stimulation during four weeks in a three-day/week basis.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (outcomes assessor)|
This group consists of treatment-as-usual for alcohol abstinence according to the Minnesota Model.
Change in the results of Frontal Assessment Battery - FAB
time frame: Before cognitive rehabilitation - After cognitive rehabilitation (1month - after 10 sessions)
Male or female participants from 18 years up to 75 years old.
Inclusion Criteria: Only patients that scored higher than the cutoff values for their age on the Mini Mental Examination Test and with no clinical scores on the Symptoms Checklist Revised were included in the study. Exclusion Criteria: Patients with dependency from substances other than alcohol or with history of previous neurological disorders were excluded from the study. Patients were also screened for minimal computer literacy; no patients were excluded due to lack of this criterion.
|Official title||Executive Functioning in Alcoholics Following a Mobile Health Cognitive Stimulation Approach: a Randomized Controlled Trial|
|Principal investigator||Jorge AG Oliveira, PhD|
Call for more information